scispace - formally typeset
R

Roland E. Schmieder

Researcher at University of Erlangen-Nuremberg

Publications -  780
Citations -  85811

Roland E. Schmieder is an academic researcher from University of Erlangen-Nuremberg. The author has contributed to research in topics: Blood pressure & Essential hypertension. The author has an hindex of 97, co-authored 717 publications receiving 78138 citations. Previous affiliations of Roland E. Schmieder include Complutense University of Madrid & University of Regensburg.

Papers
More filters
Journal ArticleDOI

Myocardial contractility and left ventricular function in obese patients with essential hypertension.

TL;DR: Although the risk of developing congestive heart failure increases in parallel with the degree of obesity, load-dependent indexes of left ventricular function are found to be reduced in patients with morbid obesity only, and some obese patients have depressed myocardial contractility despite well-preserved pump function.
Journal ArticleDOI

Hypertension and sudden death disparate effects of calcium entry blocker and diuretic therapy on cardiac dysrhythmias

TL;DR: It is concluded that antihypertensive therapy with calcium entry blockers (but not with thiazide diuretics) reduces left ventricular mass and the prevalence and severity of ventricular dysrhythmias.

Disparate Effects of Calcium Entry Blocker and Diuretic Therapy on Cardiac Dysrhythmias

TL;DR: In this article, the authors evaluated the impact of antihypertensive therapy on cardiac dysrhythmias in 13 hypertensive patients who received calcium entry blockers and in 10 hypertensive patient who received hydrochlorothiazide.
Journal ArticleDOI

Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension.

TL;DR: An observational pilot study in patients with CKD stages 3 and 4 indicates that treatment of hypertension with RDN decreases BP and slows or even halts the decline of renal function.
Journal ArticleDOI

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial.

Michel Azizi, +245 more
- 26 Jun 2021 - 
TL;DR: In this article, the authors evaluated the efficacy and safety of endovascular renal denervation in patients with hypertension resistant to three or more antihypertensive medications including a diuretic.